Introduction
Metabolic diseases such as obesity, type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), and metabolic syndrome are increasingly recognized as conditions strongly influenced by the gut microbiota.1 The human intestinal microbiome—comprising trillions of bacteria, viruses, fungi, and archaea—plays a central role in energy harvest, lipid metabolism, glucose homeostasis, and immune regulation. Dysbiosis, or disruption of microbial balance, is closely linked to insulin resistance, chronic low-grade inflammation, altered bile acid metabolism, and increased intestinal permeability, all of which contribute to metabolic dysfunction.
Gut microbiota and metabolic homeostasis
The gut microbiome influences host metabolism through multiple pathways, including short-chain fatty acid (SCFA) production, bile acid transformation, and regulation of gut barrier integrity. Beneficial microbial metabolites such as acetate, propionate, and butyrate support epithelial health, modulate appetite regulation, and improve insulin sensitivity. Conversely, dysbiosis leads to increased lipopolysaccharide (LPS) translocation, triggering metabolic endotoxemia and systemic inflammation, a key driver of metabolic disease progression.
Herbal medicines as modulators of gut microbiota
Herbal medicines exert therapeutic effects partly through modulation of the gut microbiota.
- Many phytochemicals—especially polyphenols, flavonoids, polysaccharides, and saponins—are poorly absorbed in the upper gastrointestinal tract and undergo microbial metabolism in the colon.
- This process generates bioactive metabolites that influence host metabolic signaling pathways.
- These compounds act as natural prebiotics, selectively enhancing beneficial bacteria such as Bifidobacterium, Lactobacillus, and Akkermansia muciniphila, while suppressing pathogenic or pro-inflammatory microbes. This microbial reshaping contributes to improved metabolic outcomes and reduced systemic inflammation.
Key Ayurvedic herbal formulations and bioactive effects
Traditional Ayurvedic formulations provide notable examples of microbiome-targeted therapies.
- Triphala, composed of Terminalia chebula, Terminalia bellirica, and Emblica officinalis, demonstrates prebiotic, antioxidant, and anti-inflammatory properties. It enhances SCFA production, particularly butyrate, which strengthens intestinal barrier function and improves metabolic regulation. Polyphenolic metabolites derived from Triphala, including urolithins, further exhibit anti-inflammatory and antioxidant effects.
- Curcumin from Curcuma longa has been widely studied for its ability to modulate gut microbial composition, increase beneficial bacterial populations, and reduce endotoxin-producing Gram-negative bacteria. It also suppresses NF-κB signaling pathways, thereby reducing chronic inflammation associated with insulin resistance.
- Other medicinal plants such as Withania somnifera, Ocimum sanctum, and Aloe vera contribute additional metabolic benefits through immunomodulatory, antioxidant, and gut barrier-protective actions.
Microbial metabolites and host metabolic signaling
Herbal interventions influence key microbial metabolites, including SCFAs, bile acids, and tryptophan derivatives. SCFAs regulate energy balance and glucose metabolism, while bile acid biotransformation affects signaling pathways such as FXR and TGR5, which are critical for lipid and glucose homeostasis. Through these mechanisms, herbal medicines act indirectly on host metabolic pathways via microbiota-mediated biochemical networks.
Challenges and Future Directions
Despite promising evidence, challenges remain, including inter-individual variability in microbiome composition, differences in herbal bioavailability, and lack of standardized dosing. Advances in metagenomics, metabolomics, and systems biology are improving understanding of herb–microbiome–host interactions. Future directions include personalized herbal therapies tailored to individual microbiome profiles for optimized metabolic disease management.
Conclusion
Herbal medicines represent a promising adjunct in the management of metabolic diseases by modulating gut microbiota and restoring metabolic balance. Their bidirectional interaction with the microbiome highlights a systems biology approach that integrates traditional herbal knowledge with modern microbiome science.2
References:
- Sull JW, McClain DA. Metabolic Disorders and Complications. Diabetes Metab Syndr Obes. 2025;18:4661-4663. Published 2025 Dec 20. doi:10.2147/DMSO.S579897 https://pmc.ncbi.nlm.nih.gov/articles/PMC12730181/
- Wang L, Gou X, Ding Y, et al. The interplay between herbal medicines and gut microbiota in metabolic diseases. Front Pharmacol. 2023;14:1105405. Published 2023 Mar 24. doi:10.3389/fphar.2023.1105405 https://pmc.ncbi.nlm.nih.gov/articles/PMC10079915/